Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « AbsEn.i » - entrée « impact »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
imp < impact < impacted  Facettes :

List of bibliographic references indexed by impact

Number of relevant bibliographic references: 107.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000010 (2021) Nicole Fagan [Irlande (pays)] ; Nekma Meah [Australie] ; Katherine York [Afrique du Sud] ; Laita Bokhari [Australie] ; Godfrey Fletcher [Irlande (pays)] ; Gang Chen [Australie] ; Desmond J. Tobin [Irlande (pays)] ; Andrew Messenger [Royaume-Uni] ; Alan D. Irvine [Irlande (pays)] ; Rodney Sinclair [Australie] ; Dmitri Wall [Irlande (pays)]Shedding light on therapeutics in alopecia and their relevance to COVID-19.
000021 (2021) Pierre Ekobena [Suisse] ; Anton Ivanyuk [Suisse] ; Françoise Livio [Suisse][Pharmacovigilance update].
000037 (2021) Isabel Fambuena-Muedra [Espagne] ; Marta Jiménez-García [Belgique] ; Sarah Hershko [Belgique] ; Irene Altemir-G Mez [Espagne] ; Ana Tobarra-L Pez [Espagne]What can visual caregivers expect with patients treated for SARS-CoV-2? An analysis of ongoing clinical trials and ocular side effects.
000061 (2021) Neils Ben Quashie [Ghana] ; Nancy Odurowah Duah-Quashie [Ghana]Treatment of COVID-19 with Chloroquine: Implication for Malaria Chemotherapy Using ACTs in Disease Endemic Countries.
000085 (2021) Nijad Bakhshaliyev [Turquie] ; Ramazan Özdemir [Turquie]The impact of hydroxychloroquine-azithromycin combination on Tpeak-to-end and Tpeak-to-end/QT ratio during a short treatment course.
000086 (2021) Gerard Espinosa [Espagne] ; Sergio Prieto-González [Espagne] ; Mireia Llevadot [Espagne] ; Javier Marco-Hernández [Espagne] ; Antonio Martínez-Artu A [Espagne] ; Albert Pérez-Isidro [Espagne] ; Elia Rifé [Espagne] ; Ricard Cervera [Espagne]The impact of SARS-CoV-2 coronavirus infection in patients with systemic lupus erythematosus from a single center in Catalonia.
000103 (2021) Rana Aljadeed [Arabie saoudite] ; Yazed Alruthia [Arabie saoudite] ; Bander Balkhi [Arabie saoudite] ; Ibrahim Sales [Arabie saoudite] ; Monira Alwhaibi [Arabie saoudite] ; Omar Almohammed [Arabie saoudite] ; Abdulaziz J. Alotaibi [Arabie saoudite] ; Ali M. Alrumaih [Arabie saoudite] ; Yousif Asiri [Arabie saoudite]The Impact of COVID-19 on Essential Medicines and Personal Protective Equipment Availability and Prices in Saudi Arabia.
000128 (2021) Deepak Mishra [Inde] ; Radha Raman Maurya [Inde] ; Kamlesh Kumar [Inde] ; Nupur S. Munjal [Inde] ; Vijay Bahadur [Inde] ; Sandeep Sharma [Inde] ; Prashant Singh [Inde] ; Indra Bahadur [Afrique du Sud]Structurally modified compounds of hydroxychloroquine, remdesivir and tetrahydrocannabinol against main protease of SARS-CoV-2, a possible hope for COVID-19: Docking and molecular dynamics simulation studies.
000130 (2021) Yudibeth Sixto-L Pez [Mexique] ; José Correa-Basurto [Mexique] ; Martiniano Bello [Mexique] ; Bruno Landeros-Rivera [France] ; Jose Antonio Garz N-Tiznado [Mexique] ; Sarita Monta O [Mexique]Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population.
000133 (2021) Isidro García-Meni O [Espagne] ; Lorena Forcelledo [Espagne] ; Yaiza Rosete [Espagne] ; Emilio García-Prieto [Espagne] ; Dolores Escudero [Espagne] ; Javier Fernández [Espagne]Spread of OXA-48-producing Klebsiella pneumoniae among COVID-19-infected patients: The storm after the storm.
000161 (2021) Eric Prommer [États-Unis]Safety and Utility of Chloroquine/ Hydroxychloroquine in Palliative Care Patients.
000169 (2021) Bianca D. Balmant [Brésil] ; Raquel S. Torrinhas [Brésil] ; Ilanna M. Rocha [Brésil] ; Danielle C. Fonseca [Brésil] ; Francisco F C. Formiga [Brésil] ; Eloisa S D O. Bonfá [Brésil] ; Eduardo F. Borba [Brésil] ; Dan L. Waitzberg [Brésil]SARS-CoV-2 infection, gut dysbiosis, and heterogeneous clinical results of hydroxychloroquine on COVID-19 therapy-Is there a link?
000175 (2021) Okechukwu S. Ogah [Nigeria] ; Ejiroghene M. Umuerri ; Adewole Adebiyi [Nigeria] ; Olanike A. Orimolade [Nigeria] ; Mahmoud U. Sani ; Dike B. Ojji ; Amam C. Mbakwem ; Simon Stewart ; Karen SliwaSARS-CoV 2 Infection (Covid-19) and Cardiovascular Disease in Africa: Health Care and Socio-Economic Implications.
000176 (2021) Hareesh Krishnan [Inde] ; M. Leema [Inde] ; G S Gopika [Inde] ; P M Hari Prasad [Inde] ; Abhilash Rajan [Inde] ; Arathy Anil [Inde] ; Anandhu P. Dev [Inde] ; Zeena S. Pillai [Inde]SARS CoV-2: Progression and Treatment Protocols- An Overview.
000185 (2021) Sonsoles Salto-Alejandre [Espagne] ; Silvia Jiménez-Jorge [Espagne] ; Nuria Sabé [Espagne] ; Antonio Ramos-Martínez [Espagne] ; Laura Linares [Espagne] ; Maricela Valerio [Espagne] ; Pilar Martín-Dávila [Espagne] ; Mario Fernández-Ruiz [Espagne] ; María Carmen Fari As [Espagne] ; Marino Blanes-Juliá [Espagne] ; Elisa Vidal [Espagne] ; Zaira R. Palacios-Baena [Espagne] ; Román Hernández-Gallego [Espagne] ; Jordi Carratalá [Espagne] ; Jorge Calder N-Parra [Espagne] ; María Ángeles Marcos [Espagne] ; Patricia Mu Oz [Espagne] ; Jesús Fortún-Abete [Espagne] ; José María Aguado [Espagne] ; Francisco Arnaiz-Revillas [Espagne] ; Rosa Blanes-Hernández [Espagne] ; Julián De La Torre-Cisneros [Espagne] ; Luis E. L Pez-Cortés [Espagne] ; Elena García De Vinuesa-Calvo [Espagne] ; Clara M. Rosso [Espagne] ; Jer Nimo Pach N [Espagne] ; Javier Sánchez-Céspedes [Espagne] ; Elisa Cordero [Espagne]Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study.
000267 (2021) Raymond Chee Seong Seet [Singapour] ; Amy May Lin Quek [Singapour] ; Delicia Shu Qin Ooi [Singapour] ; Sharmila Sengupta [Singapour] ; Satish Ramapatna Lakshminarasappa [Singapour] ; Chieh Yang Koo [Singapour] ; Jimmy Bok Yan So [Singapour] ; Boon Cher Goh [Singapour] ; Kwok Seng Loh [Singapour] ; Dale Fisher [Singapour] ; Hock Luen Teoh [Singapour] ; Jie Sun [Singapour] ; Alex R. Cook [Singapour] ; Paul Anantharajah Tambyah [Singapour] ; Mikael Hartman [Singapour]Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: An open-label randomized trial.
000269 (2021) Miguel Angel Martinez [Espagne]Plitidepsin: a Repurposed Drug for the Treatment of COVID-19.
000272 (2021) Tia A. Tummino ; Veronica V. Rezelj ; Benoit Fischer ; Audrey Fischer ; Matthew J. O'Meara ; Blandine Monel ; Thomas Vallet ; Ziyang Zhang ; Assaf Alon ; Henry R. O'Donnell ; Jiankun Lyu ; Heiko Schadt ; Kris M. White ; Nevan J. Krogan ; Laszlo Urban ; Kevan M. Shokat ; Andrew C. Kruse ; Adolfo García-Sastre ; Olivier Schwartz ; Francesca Moretti ; Marco Vignuzzi ; Francois Pognan ; Brian K. ShoichetPhospholipidosis is a shared mechanism underlying the in vitro antiviral activity of many repurposed drugs against SARS-CoV-2.
000283 (2021) Alina Dima [Roumanie] ; Daniel Vasile Balaban [Roumanie] ; Ciprian Jurcut [Roumanie] ; Ioana Berza [Roumanie] ; Ruxandra Jurcut [Roumanie] ; Mariana Jinga [Roumanie]Perceptions of Romanian Physicians on Lockdowns for COVID-19 Prevention.
000358 (2021) Hassan Askari [Iran] ; Nima Sanadgol [Iran, Brésil] ; Asaad Azarnezhad [Iran] ; Amir Tajbakhsh [Iran] ; Hossein Rafiei [Canada] ; Ali Reza Safarpour [Iran] ; Seyed Mohammad Gheibihayat [Iran] ; Ehsan Raeis-Abdollahi [Iran] ; Amir Savardashtaki [Iran] ; Ali Ghanbariasad [Iran] ; Navid Omidifar [Iran]Kidney diseases and COVID-19 infection: causes and effect, supportive therapeutics and nutritional perspectives.
000387 (2021) Manish Rathi [Inde] ; Parmeshar Singh [Inde] ; Hayath Peta Bi [Inde] ; Archana Shivanna [Inde] ; Chengappa Kavadichanda [Inde] ; Saumya Ranjan Tripathy ; Janani Parthasarathy [Inde] ; Sneha Tota [Inde] ; Supriya Maurya [Inde] ; Vishnupriya Vijayalekshmi [Inde] ; D. Bhavani [Inde] ; Avinash Jain [Inde] ; Ranjan Gupta [Inde] ; Debashish Danda [Inde] ; Liza Rajasekhar [Inde] ; Vir Singh Negi [Inde] ; Vineeta Shobha [Inde] ; Bidyut Das ; Amita Aggarwal [Inde]Impact of the COVID-19 pandemic on patients with systemic lupus erythematosus: Observations from an Indian inception cohort.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "impact" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "impact" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    impact
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021